12 Well being Care Shares Shifting In Friday’s After-Market Session – Sangamo Therapeutics (NASDAQ:SGMO), Ainos (NASDAQ:AIMD), ATI Bodily Remedy (NYSE:ATIP), Clearside Biomedical (NASDAQ:CLSD), Join Biopharma Hldgs (NASDAQ:CNTB), Kineta (NASDAQ:KA), Brilliant Inexperienced (NASDAQ:BGXX), Science 37 Hldgs (NASDAQ:SNCE), Gelesis Holdings (NYSE:GLS), Pieris Prescription drugs (NASDAQ:PIRS)

saikumawat029

March 18, 2023

[ad_1]

Join Biopharma Hldgs CNTB shares rose 47.3% to $1.62 throughout Friday’s after-market session. This safety traded at a quantity of 1.0 million shares come shut, making up 2307.1% of its common quantity over the past 100 days. The market worth of their excellent shares is at $89.1 million.
Gelesis Holdings GLS shares elevated by 32.72% to $0.15. The market worth of their excellent shares is at $10.7 million.
Biocept BIOC inventory elevated by 27.22% to $0.3. The corporate’s market cap stands at $5.1 million.
Clearside Biomedical CLSD inventory moved upwards by 21.14% to $1.26. The corporate’s market cap stands at $77.3 million.
Regulus Therapeutics RGLS shares elevated by 18.39% to $1.03. The corporate’s market cap stands at $17.3 million.
Kineta KA inventory moved upwards by 16.82% to $3.75. The corporate’s market cap stands at $31.1 million.

ATI Bodily Remedy ATIP shares fell 19.8% to $0.33 throughout Friday’s after-market session. The corporate’s market cap stands at $67.4 million. The corporate’s, This autumn earnings got here out yesterday.
Science 37 Hldgs SNCE inventory declined by 18.77% to $0.29. Buying and selling quantity for this safety closed at 334.3K, accounting for 41.4% of its common full-day quantity over the past 100 days. The market worth of their excellent shares is at $33.8 million.
Pieris Prescription drugs PIRS shares decreased by 13.23% to $1.05. The market worth of their excellent shares is at $78.1 million.
Ainos AIMD inventory fell 9.61% to $1.36. The market worth of their excellent shares is at $27.1 million.
Brilliant Inexperienced BGXX shares decreased by 9.59% to $0.86. The corporate’s market cap stands at $145.8 million.
Sangamo Therapeutics SGMO shares decreased by 8.96% to $1.83. Sangamo Therapeutics’s buying and selling quantity hit 93.1K shares by shut, accounting for six.2% of its common quantity over the past 100 days. The market worth of their excellent shares is at $308.3 million.
See Additionally: www.benzinga.com/cash/best-healthcare-stocks/

This text was generated by Benzinga’s automated content material engine and reviewed by an editor.

[ad_2]